The DOI matches its Crossref record; 252 of the 252 references it cites were found in a registry or an index.
Brain health: time matters in multiple sclerosis
Open accessAbstract
INTRODUCTION: We present international consensus recommendations for improving diagnosis, management and treatment access in multiple sclerosis (MS). Our vision is that these will be used widely among those committed to creating a better future for people with MS and their families. METHODS: Structured discussions and literature searches conducted in 2015 examined the personal and economic impact of MS, current practice in diagnosis, treatment and management, definitions of disease activity and barriers to accessing disease-modifying therapies (DMTs). RESULTS: Delays often occur before a person with symptoms suggestive of MS sees a neurologist. Campaigns to raise awareness of MS are needed, as are initiatives to improve access to MS healthcare professionals and services. We recommend a clear treatment goal: to maximize neurological reserve, cognitive function and physical function by reducing disease activity. Treatment should start early, with DMT and lifestyle measures. All parameters that predict relapses and disability progression should be included in the definition of disease activity and monitored regularly when practical. On suboptimal control of disease activity, switching to a DMT with a different mechanism of action should be considered. A shared decision-making process that embodies dialogue and considers all appropriate DMTs should be implemented. Monitoring data should be recorded formally in registries to generate real-world evidence. In many jurisdictions, access to DMTs is limited. To improve treatment access the relevant bodies should consider all costs to all parties when conducting economic evaluations and encourage the continuing investigation, development and use of cost-effective therapeutic strategies and alternative financing models. CONCLUSIONS: The consensus findings of an international author group recommend a therapeutic strategy based on proactive monitoring and shared decision-making in MS. Early diagnosis and improved treatment access are also key components.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–252 of 252
Schwartz, C. E., Quaranto, B. R., Healy, B. C., Benedict, R. H. B., & Vollmer, T. L. (2013) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2013.05.009 · Cited by 61
Self-citationThe Path to Self-Management: A Qualitative Study Involving Older People with Multiple Sclerosis
Ploughman, M., Austin, M. W., Murdoch, M., Kearney, A., Godwin, M. S., & Stefanelli, M. (2011) · Physiotherapy Canada · doi:10.3138/ptc.2010-42 · Cited by 60
Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts
Kingwell, E., Leung, A. L., Roger, E., Duquette, P., Rieckmann, P., & Tremlett, H. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.02.007 · Cited by 60
New treatments and treatment goals for patients with relapsing-remitting multiple sclerosis
Fox, E., & Rhoades, R. W. (2012) · Current Opinion in Neurology · doi:10.1097/01.wco.0000413320.94715.e9 · Cited by 58
Turner, A. P., Sloan, A. P., Kivlahan, D. R., & Haselkorn, J. K. (2014) · Rehabilitation Psychology · doi:10.1037/a0036322 · Cited by 57
Pinter, D., Sumowski, J. F., DeLuca, J., Fazekas, F., Pichler, A., Khalil, M., Langkammer, C., Fuchs, S., & Enzinger, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087567 · Cited by 57
HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica
Asgari, N., Nielsen, C., Stenager, E., Kyvik, K. O., & Lillevang, S. T. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511417480 · Cited by 57
Substantial early, but nonprogressive neuronal loss in multiple sclerosis (ms) spinal cord
Schirmer, L., Albert, M., Buss, A., Schulz‐Schaeffer, W. J., Antel, J. P., Brück, W., & Stadelmann, C. (2009) · Annals of Neurology · doi:10.1002/ana.21799 · Cited by 56
The McDonald Criteria for Multiple Sclerosis: time for clarification
Hawkes, C. H., & Giovannoni, G. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510362441 · Cited by 55
Self-citationRovaris, M., Comi, G., Rocca, M. A., Valsasina, P., Ladkani, D., Pieri, E., Weiss, S., Shifroni, G., Wolinsky, J. S., Filippi, M., et al. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506070704 · Cited by 54
School performance as a marker of cognitive decline prior to diagnosis of multiple sclerosis
Sinay, V. J., Akly, M. P., Zanga, G., Ciardi, C., & Racosta, J. M. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514554054 · Cited by 54
The role of specialist nurses in multiple sclerosis: a rapid and systematic review
Broe, S. D., Christopher, F., & Waugh, N. R. (2001) · Health Technology Assessment · doi:10.3310/hta5170 · Cited by 53
Wu, M., Sirota, M., Butte, A. J., & Chen, B. (2014) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814644730_0008 · Cited by 49
Predictors of disability worsening in clinically isolated syndrome
Jokubaitis, V., Spelman, T. D., Kalinčík, T., Izquierdo, G., Grand’Maison, F., Duquette, P., Girard, M., Lugaresi, A., Grammond, P., Hupperts, R., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.187 · Cited by 49
Self-citationRelapsing-Remitting Multiple Sclerosis
urer, M. M., & Rieckmann, P. (2000) · BioDrugs · doi:10.2165/00063030-200013030-00001 · Cited by 48
Kobelt, G., Texier-Richard, B., & Lindgren, P. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509102771 · Cited by 48
Self-citationSerum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients
Gresle, M. M., Liu, Y., Dagley, L. F., Haartsen, J., Pearson, F., Purcell, A. W., Laverick, L., Petzold, A., Lucas, R. M., van der Walt, A., et al. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306789 · Cited by 48
Self-citationEpstein–Barr virus, latitude and multiple sclerosis
Disanto, G., Pakpoor, J., Morahan, J. M., Hall, C., Meier, U., Giovannoni, G., & Ramagopalan, S. V. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512451942 · Cited by 45
Self-citationO'Connor, P. W. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80339-9 · Cited by 45
Robinson, A. G., Booth, C. M., & Eisenhauer, E. A. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.05.024 · Cited by 44
Goodin, D. S., Ebers, G. C., Cutter, G., Cook, S. D., O'Donnell, T., Reder, A. T., Kremenchutzky, M., Oger, J., Rametta, M., Beckmann, K., et al. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001972 · Cited by 44
Hughes, S., Spelman, T., Trojano, M., Lugaresi, A., Izquierdo, G., Grand’Maison, F., Duquette, P., Girard, M., Grammond, P., Oreja-Guevara, C., et al. (2012) · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · doi:10.1136/jnnp-2011-301051 · Cited by 43
Telemedicine for multiple sclerosis patients: assessment using Health Value Compass
Zissman, K., Lejbkowicz, I., & Miller, A. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511421918 · Cited by 43
Kalinčík, T., Jokubaitis, V., Izquierdo, G., Duquette, P., Girard, M., Grammond, P., Lugaresi, A., Oreja‐Guevara, C., Bergamaschi, R., Hupperts, R., et al. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514559865 · Cited by 43
Self-citationKarampampa, K., Gustavsson, A., van Munster, E. T. L., Hupperts, R., Sanders, E. A. C. M., Mostert, J. P., Sinnige, O. L. G. F., de Graaf, J., Pop, P., Miltenburger, C., et al. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2013.807267 · Cited by 42
MRI correlates of disability progression in patients with CIS over 48 months
Uher, T., Horáková, D., Bergsland, N., Týblová, M., Ramasamy, D. P., Seidl, Z., Vaněčková, M., Krásenský, J., Havrdová, E., & Zivadinov, R. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.09.015 · Cited by 40
Fahrbach, K. R., Huelin, R., Martin, A. L., Kim, E., Dastani, H. B., Rao, S. M., & Malhotra, M. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-180 · Cited by 40
Miravitlles, M., Sicras, A., Crespo, C., Cuesta, M., Brosa, M., Galera, J., Lahoz, R., Lleonart, M., & Riera, M. I. (2013) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465813484080 · Cited by 39
Yamout, B., Alroughani, R., Aljumah, M., Gouider, R., Dahdaleh, M., Inshasi, J. S. S., Hashem, S., Alsharoqi, I., Sahraian, M. A., Khoury, S. J., et al. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1047750 · Cited by 38
Association between smoking and cognitive impairment in multiple sclerosis
Özcan, M. E., Asil, T., İnce, B., Bingöl, A., Ertürk, S., Altinoz, M. A., Karadeli, H. H., & Koçer, A. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s68389 · Cited by 38
Caregiving in Multiple Sclerosis
Hillman, L. (2013) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2013.06.007 · Cited by 38
Perceptions of Health Status in Multiple Sclerosis Patients and Their Doctors
Kremenchutzky, M., & Walt, L. (2013) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013755 · Cited by 38
Beta‐interferon exposure and onset of secondary progressive multiple sclerosis
Zhang, T., Shirani, A., Zhao, Y., Karim, M. E., Gustafson, P., Petkau, J., Evans, C. D., Kingwell, E., van der Kop, M., Zhu, F., et al. (2015) · European Journal of Neurology · doi:10.1111/ene.12698 · Cited by 36
Multiple sclerosis, from referral to confirmed diagnosis: an audit of clinical practice
Kelly, S., Chaila, E., Kinsella, K., Duggan, M., McGuigan, C., Tubridy, N., & Hutchinson, M. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511403643 · Cited by 30
Duddy, M., Lee, M., Pearson, O. R., Nikfekr, E., Chaudhuri, A., Percival, F., Roberts, M., & Whitlock, C. (2014) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2014.02.006 · Cited by 29
Romeo, M. A. L., Boneschi, F. M., Rodegher, M., Esposito, F., Martinelli, V., & Comı, G. (2013) · European Journal of Neurology · doi:10.1111/ene.12119 · Cited by 29
Delay in the diagnosis of multiple sclerosis in Croatia
Adamec, I., Barun, B., Gabelić, T., Zadro, I., & Habek, M. (2013) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.09.025 · Cited by 28
The Evolving Role of the Multiple Sclerosis Nurse
Burke, T. V., Dishon, S., McEwan, L., & Smrtka, J. (2011) · International Journal of MS Care · doi:10.7224/1537-2073-13.3.105 · Cited by 27
Value and goals of treat-to-target in systemic lupus erythematosus: knowledge and foresight
Doria, A., Gatto, M., Iaccarino, L., & Punzi, L. (2015) · Lupus · doi:10.1177/0961203314559087 · Cited by 27
Russo, P., Capone, A., Paolillo, A., Macchia, F., Ranzato, F., Costantino, G., Esposti, L. D., & Caprino, L. (2004) · Clinical Drug Investigation · doi:10.2165/00044011-200424070-00004 · Cited by 26
Pugliatti, M., Eskic, D., Mikolcić, T., Pitschnau‐Michel, D., Myhr, K. M., Sastre‐Garriga, J., Otero‐Romero, S., Wieczynska, L., Torje, C., Holloway, E. P. M., et al. (2012) · Acta Neurologica Scandinavica · doi:10.1111/ane.12024 · Cited by 26
Self-citationPractice patterns of US neurologists in patients with CIS, RRMS, or RIS
Tornatore, C., Phillips, J. T., Khan, O., Miller, A., & Barnes, C. J. (2012) · Neurology Clinical Practice · doi:10.1212/cpj.0b013e31824cb09b · Cited by 25
Survival and mortality rates among Danes with MS.
Brønnum‐Hansen, H., Stenager, E., Hansen, T., & Koch-Henriksen, H. (2006) · PubMed · Cited by 24
Willis, H., Webster, J., Larkin, A. M., & Parkes, L. (2014) · Patient Preference and Adherence · doi:10.2147/ppa.s54986 · Cited by 24
Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and Monitoring
Traboulsee, A. L., Guillon, L. L., Freedman, M. S., O'Connor, P. W., Bharatha, A., Chakraborty, S., Girard, J. M., Giuliani, F., Lysack, J. T., Marriott, J. J., et al. (2015) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2015.24 · Cited by 24
Self-citationReasons patients give to use or not to use immunomodulating agents for multiple sclerosis
Visser, L. H., & van der Zande, A. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03411.x · Cited by 23
Runia, T. F., Jafari, N., & Hintzen, R. Q. (2013) · European Journal of Neurology · doi:10.1111/ene.12243 · Cited by 22
Confounding in association studies: month of birth and multiple sclerosis
Fiddes, B., Wason, J. M. S., & Sawcer, S. J. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7241-y · Cited by 22
Identifying responders and nonresponders to interferon therapy in multiple sclerosis
Prosperini, L., Capobianco, M. A. N., & Giannì, C. (2014) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s42734 · Cited by 13
Photoimmunology and Multiple Sclerosis
Marsh‐Wakefield, F., & Byrne, S. N. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_359 · Cited by 11
Multiple sclerosis disease modifying medicine utilisation in Australia
Hollingworth, S., Walker, K., Page, A., & Eadie, M. J. (2014) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2014.05.034 · Cited by 6
Kieseier, B. C. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.869478 · Cited by 3
Cited by
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
New insights into the burden and costs of multiple sclerosis in Europe
Kobelt, G., Thompson, A., Berg, J., Gannedahl, M., Eriksson, J., the MSCOI Study Group, & Platform, T. E. M. S. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517694432 · Cited by 733
Self-citationDynamics of oligodendrocyte generation in multiple sclerosis
Yeung, M. S. Y., Djelloul, M., Steiner, E., Bernard, S., Salehpour, M., Possnert, G., Brundin, L., & Frisén, J. (2019) · Nature · doi:10.1038/s41586-018-0842-3 · Cited by 376
Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
Baker, D., Marta, M., Pryce, G., Giovannoni, G., & Schmierer, K. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.01.042 · Cited by 289
Self-citationDalgas, U., Langeskov-Christensen, M., Stenager, E., Riemenschneider, M., & Hvid, L. G. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-1002-3 · Cited by 287
Metadata
- Authors
- Giovannoni, G., Butzkueven, H., Dhib-Jalbut, S., Hobart, J., Kobelt, G., Pepper, G., Sormani, M. P., Thalheim, C., Traboulsee, A., & Vollmer, T.
- Venue
- Multiple Sclerosis and Related Disorders
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 9
- Pages
- S5-S48
- ISSN
- 2211-0348 (ISSN-L)
- OpenAlex
- W2463810424
- Cited by
- 458
- References
- 252
- FWCI
- 24.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.